Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women - a cross-racial validation

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 10, 2008, Pages 671-677

  Hwang, Juey Jen ^a   Li, Hung Yuan ^a   Shieh, Gow Jen ^a   Chien, Yu Fen ^a   Hua, Cyue Huei ^a   Lin, Jou Wei ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Acute phase proteins; Diagnosis, screening; Models, structural; Syndrome X, metabolic

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHYSIOLOGY; STATISTICAL MODEL;

ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, STATISTICAL; OBESITY;

EID: 55949134974     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2007.11.006     Document Type: Article

References (29)

1. Pearson T.A., Mensag G.A., Wong Y., Smith Jr. S.C., and for the Center of Diseases Control and Prevention and the American Heart Association. Workshop on Markers of Inflammation and Cardiovascular Diseases: application to clinical and public health practice: overview. Circulation 110 (2004) e543-e544
2. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
3. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
4. Clearfield M.B. C-reactive protein: a new risk assessment tool for cardiovascular diseases. JAOA 105 (2005) 409-416
5. Toss H., Lindahl B., Siegbahn A., and Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Frisc Study Group. Fragmin during instability in coronary artery disease. Circulation 96 (1997) 4204-4210
6. Morrow D.A., Rifai N., Antman E.M., Weiner D.L., McCabe C.H., Cannon C.P., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11a Substudy. Thrombolysis in myocardial infarction. J Am Coll Cardiol 31 7 (1998) 1460-1465
7. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363
8. Adam F.M., Nara M.G., and Adam J.M. Fasting insulin, adiponectin, hs-CRP levels, and the components of metabolic syndrome. Acta Med Indones 38 4 (2006) 179-184
9. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107 3 (2003 Jan) 391-397
10. Zambon A., Pauletto P., and Crepaldi G. The metabolic syndrome-a chronic cardiovascular inflammatory condition. Aliment Pharmacol Ther 22 Suppl 2 (2005) 20-23
11. Lim S., Lee H.K., Kimm K.C., Park C., Shin C., and Cho N.H. C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. CRP as risk factor of metabolic syndrome. Diabetes Res Clin Pract 70 2 (2005) 126-133
12. Moran A., Steffen L.M., Jacobs Jr. D.R., Steinberger J., Pankow J.S., Hong C.P., et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth. Diabetes Care 28 7 (2005) 1763-1768
13. Lin LY, Kuo HK, Li HY, Lin JW. Confirming a biological pathway among the components of the metabolic syndrome - insight from the National Health and Nutrition Examination Survey 1999-2002 Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference 2007, Chicago, USA.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
15. Population statistics in Taiwan. Report of the Minister of Interior, Taiwan (2005). http://www.ris.gov.tw/ch4/static/st10-1.xls [retrieved on 16 April 2007]
16. Lin J.W., Hwang J.J., Dai D.F., and Tseng Y.Z. Using structural equation model to illustrate the relationship between metabolic risk factors and cardiovascular complications in Taiwan. Eur J Cardiovasc Prevent Rehab 13 (2006) 633-639
17. Alberti K.G., Zimmet P., and Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 366 9491 (2005) 1059-1062
18. International Diabetes Federation, The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf
19. Santos A.C., Lopes C., Guimaraes J.T., and Barros H. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome. Int J Obes (Lond) 29 12 (2005) 1452-1456
20. Aronson D., Bartha P., Zinder O., Kerner A., Markiewicz W., Avizohar O., et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord J Int Assoc Study Obes 28 5 (2004) 674-679
21. Piche M.E., Lemieux S., Weisnagel S.J., Corneau L., Nadeau A., and Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 96 1 (2005) 92-97
22. Niskanen L., Laaksonen D.E., Nyyssonen K., Punnonen K., Valkonen V.P., Fuentes R., et al. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 44 6 (2004) 859-865
23. Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., and Ridker P.M. C-reactive protein and the risk of developing hypertension. J Am Med Assoc 290 (2003) 2945-2951
24. Hoekstra T., Geleijnse J.M., Schouten E.G., Kok F.J., and Kluft C. Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly. Nutr Metab Cardiovasc Dis 15 4 (2005) 270-278
25. Sarafidis P.A., and Bakris G.L. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?. J Hum Hypertens 21 1 (2007) 12-19
26. Kolanowski J. Obesity and hypertension: from pathophysiology to treatment. Int J Obes Relat Metab Disord 23 Suppl (1999) 42-46
27. Timpson N.J., Lawlor D.A., Harbord R.M., Gaunt T.R., Day I.N., Palmer L.J., et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366 9501 (2005) 1954-1959
28. Nakanishi N., Shiraishi T., and Wada M. Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study. Diabetes Res Clin Pract 69 1 (2005) 88-98
29. Yao W.J., Wu C.H., Wang S.T., Chang C.J., Chiu N.T., and Yu C.Y. Differential changes in regional bone mineral density in healthy Chinese: age-related and sex-dependent. Calcif Tissue Int 68 6 (2001) 330-336